C12N 2770/24021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2770/24021 (Viruses as such) appears on 5 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 9
- Assignees
- 9
- Inventors
- 36
- Latest grant
- 10 Dec 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 3 |
| 2016 | 0 | 0 |
| 2017 | 2 | 1 |
| 2018 | 2 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
- Compositions and methods for detecting human pegivirus 2 (HPgV-2)10 Dec 2019US 10,501,816 B2Abbott Laboratories
- Immunogenic compositions comprising silicified virus and methods of use12 Jun 2018US 9,993,543 B2Portland State University
- Compositions and methods for detecting human pegivirus 2 (HPgV-2)10 Apr 2018US 9,938,589 B2Abbott Laboratories
- Flavivirus associated with Theiler's disease7 Nov 2017US 9,809,863 B2Cornell University
- Compositions and methods for detecting human Pegivirus 2 (HPgV-2)3 Oct 2017US 9,777,340 B2Abbott Laboratories
- Defective interfering viral genomes8 Jun 2023US 2023/0174953 A1
- Nucleic acid molecules inserted expression regulation sequences, expression vector comprising nucleic acid moleclues and pharmaceutical use thereof4 Nov 2021US 2021/0340550 A1The Catholic University of Korea Industry-Academic Cooperation Foundation
- Combination of immuno-oncolytic virus drugs for enhancing systemic immune response and application thereof9 Jul 2020US 2020/0215133 A1Sichuan Oncocare Biopharmaceutical, Inc.
- Compositions and methods for detecting human pegivirus 2 (hpgv-2)16 Apr 2020US 2020/0115767 A1Abbott Laboratories
- Compositions and methods for detecting human pegivirus 2 (hpgv-2)16 Aug 2018US 2018/0230555 A1Abbott Laboratories
Most cited
By later US patents